Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Indivior Pharmaceuticals (INDV) Tax Rate (2022 - 2025)

Historic Tax Rate for Indivior Pharmaceuticals (INDV) over the last 4 years, with Q3 2025 value amounting to 13.51%.

  • Indivior Pharmaceuticals' Tax Rate fell 401800.0% to 13.51% in Q3 2025 from the same period last year, while for Sep 2025 it was 34.18%, marking a year-over-year increase of 597700.0%. This contributed to the annual value of 65.0% for FY2024, which is 519000.0% up from last year.
  • According to the latest figures from Q3 2025, Indivior Pharmaceuticals' Tax Rate is 13.51%, which was down 401800.0% from 70.97% recorded in Q2 2025.
  • In the past 5 years, Indivior Pharmaceuticals' Tax Rate ranged from a high of 70.97% in Q2 2025 and a low of 37.1% during Q2 2023
  • For the 4-year period, Indivior Pharmaceuticals' Tax Rate averaged around 0.97%, with its median value being 12.49% (2025).
  • As far as peak fluctuations go, Indivior Pharmaceuticals' Tax Rate soared by 562100bps in 2024, and later crashed by -401800bps in 2025.
  • Quarter analysis of 4 years shows Indivior Pharmaceuticals' Tax Rate stood at 28.52% in 2022, then soared by 60bps to 11.48% in 2023, then skyrocketed by 490bps to 44.74% in 2024, then tumbled by -130bps to 13.51% in 2025.
  • Its Tax Rate stands at 13.51% for Q3 2025, versus 70.97% for Q2 2025 and 18.64% for Q1 2025.